Search

everythinglearnresearchcommunity

for

Search:↓

The Rotterdam Study investigates diseases in older adults and has produced many research findings.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Most adult chronic hair pullers are women who started in their early teens, often have other mental health issues, and may pull hair due to underlying psychiatric conditions.

Fluoxetine was not effective in treating hair-pulling disorder in the short term.

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Testosterone improves mood and thinking skills; finasteride has no effect.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Women with PCOS have more emotional and body image issues than healthy women.

People with first-time vitiligo have lower levels of a certain brain protein compared to healthy individuals.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Gut flora changes could potentially indicate depression, but more research is needed.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

New medications are improving depression treatment, emphasizing accurate diagnosis and chronic care.

Most women with depression in the study had low vitamin D levels.

Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.

Lifestyle changes like diet and exercise are key for treating overweight women with polycystic ovary syndrome.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Trichotillomania is more common than previously thought, with increasing diagnosed cases.

Managing diabetes can lead to eating disorders, and eating disorders can make diabetes harder to control.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

People with hair loss conditions often have more mental health issues like depression and anxiety compared to those without hair loss.

Antidepressants may improve or resolve scalp dysesthesia in most patients.